Genscript Biotech Stock

Genscript Biotech Dividend

Delisted·Jun 18, 2026

Dividend of Genscript Biotech (1548.HK) as of Jul 27, 2026.

Dividend

0.00USD

Dividend yield

0.80 %

Last updated:

How much dividend does Genscript Biotech 2026 pay?

According to the latest status from July 2026, Genscript Biotech paid a total of 0.00 USD per share in dividends within the last 12 months. With the current Genscript Biotech price of 1.50 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Genscript Biotech currently offers a dividend yield of about 0.80%. The payout ratio is around 10% of earnings.

Historical Genscript Biotech Dividends

PaydateDividend
7/5/20170.01USD

Is the Genscript Biotech Dividend Safe?

Genscript Biotech has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Genscript Biotech dividend payout ratio

In 2025, Genscript Biotech had a payout ratio of 10.14%. The payout ratio indicates the percentage of the company's profits that Genscript Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
10.14 %
Jan 1, 2022
10.14 %
Jan 1, 2023
10.14 %
Jan 1, 2024
10.14 %
Jan 1, 2025
10.14 %
Jan 1, 2026 (e)
16.42 %
Jan 1, 2027 (e)
9.70 %
Jan 1, 2028 (e)
5.60 %

Dividend Details

Understanding Genscript Biotech's Dividend Distributions

Genscript Biotech’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Genscript Biotech's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Genscript Biotech's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Genscript Biotech’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

Over the past 12 months, Genscript Biotech paid a dividend of 0.01 USD . This corresponds to a dividend yield of about 0.80 %. For the coming 12 months, Genscript Biotech is expected to pay a dividend of 0.01 USD.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Genscript Biotech